Publications
Publications taken from Cristin:
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Jacques-Eric Gottenberg
“You don't put it down to arthritis”: A qualitative study of the first symptoms recalled by individuals with knee osteoarthritis
LK King, A. Mahmoudian, EJ Waugh, I. Stanaitis, M. Gomes, V. Hung
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration
Celina K. Gehringer, Glen P. Martin, Kimme L. Hyrich, Suzanne MM Verstappen, Joseph Sexton, Eirik Kristianslund
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity
Karen Holten, Nina Paulshus Sundlisæter, Joseph Sexton, Lena Bugge Nordberg, Till Uhlig, Tore Kristian Aaserud Kvien
A perspective on the evolution of semi-quantitative MRI assessment of osteoarthritis: Past, present and future
Frank W. Roemer, Mohamed Jarraya, Daichi Hayashi, Michel D. Crema, Ida Kristin Bos-Haugen, David J. Hunter
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update
Tuva Moseng, Theodora PM Vliet Vlieland, Simone Battista, David Beckwée, Vladimira Boyadzhieva, Philip G. Conaghan
Assessing the association of epigenetic age acceleration with osteoarthritis in the Multicenter Osteoarthritis Study (MOST)
Michelle S. Yau, Paul C. Okoro, Ida Kristin Bos-Haugen, John A. Lynch, Michael C. Nevitt, Cora E. Lewis
Patient Involvement in the Rehabilitation Process Is Associated with Improvement in Function and Goal Attainment: Results from an Exploratory Longitudinal Study
Joachim Støren Sagen, Ingvild Kjeken, Andreas Hanssønn Habberstad, Anita Dyb Linge, Ann Elisabeth Simonsen, Anne Dorte Lyken
Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: The ExeHeart randomized controlled trial
Kristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, Jonny Hisdal, Joseph Sexton, Camilla Fongen
Erosive hand osteoarthritis and sarcopenia: data from the Osteoarthritis Initiative cohort
Kamyar Moradi, Robert M. Kwee, Bahram Mohajer, Ali Guermazi, Frank W. Roemer, Hamza Ahmed Ibad
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Bjorn Gudbjornsson
A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study
Sella Aarrestad Provan, F. Ahlfors, Gunnstein Bakland, Yi Hu, EK Kristianslund, Eirik Ikdahl
Associations of inflammatory and metabolic biomarkers with incident erosive hand osteoarthritis in the osteoarthritis initiative cohort
Timothy E. McAlindon, Jennifer L. Hunnicutt, Mary B. Roberts, Ida Kristin Bos-Haugen, Lena F. Schaefer, Jeffrey B. Driban
Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region
Khalid A. Alnaqbi, Nasra Al Adhoubi, Sara Aldallal, Samar Al Emadi, Adeeba Al-Herz, Amin M. El Shamy
Modifiable prognostic factors of high societal costs among people on sick leave due to musculoskeletal disorders: findings from an occupational cohort study
Rikke Munk Killingmo, Anne Therese Tveter, Are Hugo Pripp, Alexander Tingulstad, Esther Maas, Tarjei Langseth Rysstad
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid Marie Egner, Trung The Tran, Lisa Tietze
Participatory Development of a Virtual Reality Exercise Program for People with Chronic Pain
Sella Aarrestad Provan, Giovanna Calogiuri, Sigbjørn Litleskare, Linda Røset, Henning Pettersen, Ole E. Flaten
Current and Future Challenges for Rehabilitation for Inflammatory Arthritis
Rikke Helene Moe, Thea PM Vliet Vlieland
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyzes of the randomised, controlled NOR-DRUM trials
Marthe Kirkesæther Brun, Johanna Gehin, Kristin Reine Hammersbøen, David Warren, Rolf Klaasen, Joseph Sexton
Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort
MP Jansen, D. Hodgins, SC Mastbergen, M. Kloppenburg, FJ Blanco, Ida Kristin Bos-Haugen
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Nabil V. Sayour, Giorgio Minotti, Massimiliano Camilli, Gianluigi Savarese, Juan-Carlos Kaski, Zoltán V. Varga
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomized controlled, non-inferiority trial
Kaja Eriksrud Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad
Long-term changes in pain and function in patients with thumb base osteoarthritis receiving brief information, occupational therapy and/or surgery
Anne Therese Tveter, Nina Østerås, Randi Nossum, Ruth Else Meh Eide, Åse Klokkeide, Karin Hoegh Matre
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment
Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, Lennart Jacobsson, Michael J. Nissen, Eirik Kristianslund
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
Hilde Sofie Sager Ørbo, Kristin Reine Hammersbøen, Joseph Sexton, Ingrid Jyssum, Anne Therese Tveter, Ingrid Egeland Christensen
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study
Violetta Dubovyk, Georgios K. Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom
Glossary of national professional guidelines from the Norwegian Directorate of Health
Lise Mørkved Helsingen, Eline Aurvoll Langeland, Synne Eline Rotihaug Pisani, Per Olav Vandvik, Espen A. Haavardsholm, Ulrik Fredrik Malt
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Mads Sundet, Ulf Gunnar Sundin, Aasmund Godø, Kristian Sydnes, Haldor Valland, Joseph Sexton
Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort
Alexandre Sepriano, Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Sarah Ohrndorf, Olivier FitzGerald
Gender differences in patterns of cartilage loss: Data from the Osteoarthritis Initiative
Rebecca Amesbury, Hedieh Ragati-Haghi, Alexander Mathiessen, Todd Laffaye, Rebekah I. Stein, Jamie E. Collins
Hand osteoarthritis phenotypes based on a biopsychosocial approach, and their associations with cross-sectional and longitudinal pain
Elisabeth Mulrooney, Tuhina Neogi, Hanne Dagfinrud, Hilde Berner Hammer, Pernille Steen Pettersen, Tore Kristian Aaserud Kvien
Five-Year Results of the Salto XT Revision Ankle Arthroplasty
Mads Sundet, Karen Sandvik Gyllensten, Eva Hansen Dybvik, Kari Eikvar, Geir Hallan, Siri Lillegraven
Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohort
Sietse ES Terpstra, Lotte A. van de Stadt, Francis Berenbaum, Francisco J. Blanco, Ida Kristin Bos-Haugen, Simon C. Mastbergen
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A Dan
2023 EULAR classification criteria for hand osteoarthritis
Ida Kristin Bos-Haugen, David T. Felson, Abhishek Abhishek, Francis Berenbaum, Sita Bierma-Zeinstra, Krysia S. Dziedzic
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries
Eleana Bolla, Anne Grete Semb, Anne M Kerola, Eirik Ikdahl, Michelle Petri, Guillermo J Pons-Estel
Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depression
Brigitte Michelsen, Joseph Sexton, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien, Hilde Berner Hammer
Presentation of the first international research network to foster high-quality clinical trials testing non-pharmacological interventions (TRACTION network)
Ricardo JO Ferreira, Adriana Henriques, Rikke Helene Moe, Cristiano Matos, Anne Therese Tveter, Nina Østerås
Who Does What in Hand Osteoarthritis Care? A Qualitative Study of Boundary Work Between Rheumatologists and Occupational Therapists in Norway
Silje Zink, Ingvild Kjeken, Marte Feiring
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Karel Pavelka
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore Kristian Aaserud Kvien, Daniela Di Giuseppe, Johan K. Wallman
Biological use influences the impact of inflammation on the risk of major adverse cardiovascular events in rheumatoid arthritis
George Athanasios Karpouzas, Sarah R. Ormseth, Piet Leonardus Cornelis Maria van Riel, Miguel A. Gonzalez-Gay, Alfonso Corrales, Solbritt Rantapää-Dahlqvist
Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study
Emil E. Kvernberg Thomassen, Inger Jorid Berg, Eirik Kristianslund, Anne Therese Tveter, Gunnstein Bakland, Laure Gossec
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
Paul M. Haller, Niema Kazem, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Dobromir Dobrev
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
Louise Linde, Stylianos Georgiadis, Lykke M. Ørnbjerg, Simon H. Rasmussen, Brigitte Michelsen, Johan Askling
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomized controlled trial
Kristina Lend, Jon Lampa, Leonid Padyukov, Merete Lund Hetland, Marte Schrumpf, Dan C Nordström
The natural history of marginal erosions in hands with and without osteoarthritis
Hari A. Sharma, Timothy E. McAlindon, Mary B. Roberts, Ida Kristin Bos-Haugen, Grace H. Lo, Jeffrey Duryea
Interstitial lung disease in rheumatoid or psoriatic arthritis patients initiating biologics, and controls - data from five Nordic registries
Sella Aarrestad Provan, Eirik Klami Kristianslund, Brigitte Michelsen, Tillmann Uhlig, Joseph Sexton, Tore Kristian Aaserud Kvien
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
Karen Holten, Nina Paulshus Sundlisæter, Joseph Sexton, Kaja Eriksrud Kjørholt, Lena Bugge Nordberg, Tillmann Uhlig
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Louise Linde, Lykke M. Ørnbjerg, Stylianos Georgiadis, Simon H. Rasmussen, Ulf Lindström, Johan Askling
Recommendations for effective collaboration and capacity building in epidemiological studies on the effect of alcohol and drug use on traffic safety in low- and middle-income countries
Hallvard Gjerde, Marilyn A. Huestis, Gift Mulima, Chifundo Kajombo, Mads Sundet, Flavio Pechansky
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
Lykke M. Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon H. Rasmussen, Lennart Jacobsson, Anne G. Loft
The hip fracture incidence in the high-risk area Oslo continues to decline
Ingvild Hestnes, Lene Bergendal Solberg, Haakon Eduard Meyer, Mads Sundet, Raju Rimal, Lars Nordsletten
Examining the Building Blocks of Health Behavior Change in Rheumatology Rehabilitation: A Theory-Driven Qualitative Study
Gunnhild Berdal, Ingvild Kjeken, Anita Dyb Linge, Ann Margret Aasvold, Kjetil Tennebø, Siv Grødal Eppeland
Glycerol Handling in Paired Visceral and Subcutaneous Adipose Tissues in Women with Normal Weight and Upper-Body Obesity
Anne Nørholm, Ida Guldbrandt Kjær, Esben Søndergaard Bruun Olesen, Birgitte Nellemann, Søren Nielsen, Janne Lebeck
Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes - results from the NOR-Gout study
Tillmann Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Sella Aarrestad Provan, Espen Andre Haavardsholm, Hilde Berner Hammer
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
Asia-Sophia Fumika Michaela Wolf, Kristin Reine Hammersbøen, Hilde Sofie Sager Ørbo, Sabin Bhandari, Guri Solum, Ingrid Fadum Kjønstad
Biological material for biomarker research in spondyloarthritis: mapping the availability in European rheumatology registries
Bente Glintborg, Mikkel Østergaard, Jacob Brauner Jørgensen, Johan Karlsson Wallman, Burkhard Möller, Michael John Nissen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort
Mary Lucy Marques, Sofia Ramiro, Miranda van Lunteren, Rosalinde Anne Stal, Robert BM Landewé, Marleen van de Sande
Lessons learned from the PICASSO trial regarding ultrasound examinations of osteoarthritic hand joints performed by occupational therapists
Marthe Gløersen, Merete Hermann-Eriksen, Åshild Hove, Ingvild Kjeken, Alexander Mathiessen, Hilde Berner Hammer
Usage, Attitudes, Facilitators, and Barriers Toward Digital Health Technologies in Musculoskeletal Care: Survey Among Primary Care Physiotherapists in Norway
Lars Martinsen, Nina Østerås, Tuva Moseng, Anne Therese Tveter
Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after two years?
Ana Bento da Silva, Sofia Ramiro, Anne Boel, Miranda van Lunteren, Mary Lucy Marques, Marleen van de Sande
Circulating Baseline CXCR3 + Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis
Julia M. Scheffler, Christina Drevinge, Catharina Lindholm, Inger Gjertsson, Kristina Lend, Merete Lund Hetland
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
Georgios K. Vasileiadis, Yuan Zhang, Tahzeeb Fatima, Ronald van Vollenhoven, Jon Lampa, Bjorn Gudbjornsson
Fluctuation of Bone Marrow Lesions and Inflammatory MRI Markers over 2 Years and Concurrent Associations with Quantitative Cartilage Loss
Frank W. Roemer, Mylène P. Jansen, Susanne Maschek, Simon C. Mastbergen, Anne-Karien Marijnissen, Anna Wisser
Development of the Happy Hands Self-Management App for People with Hand Osteoarthritis: Feasibility Study
Anne Therese Tveter, Cecilie Varsi, Marit Kristin Maarnes, Stein Jarle Pedersen, Barbara Therese Slatkovsky Christensen, Thale Beate Blanck
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
Leticia Kawano-Dourado, Eirik Kristianslund, Dena Zeraatkar, Meghna Jani, Govind Makharia, Glen Hazlewood
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries
Lykke M. Ørnbjerg, Stylianos Georgiadis, Tore Kristian Aaserud Kvien, Brigitte Michelsen, Simon Rasmussen, Karel Pavelka
Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort
Sarah Stewart, Greg Gamble, William Taylor, Isabel Su, Tony Merriman, Borislav Mihov
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, Xavier Rossello, Marianna Adamo, James Ainslie
Therapeutic serum level for adalimumab in rheumatoid arthritis: exploratory analyzes of data from a randomized phase III trial
Johanna Gehin, Rolf Klaasen, Eirik Kristianslund, Ingrid Jyssum, Joseph Sexton, David Warren
Longitudinal stability of molecular endotypes of knee osteoarthritis patients
Monica T. Hannani, Christian S. Thudium, Alfred C. Gellhorn, Jonathan Larkin, Morten A. Karsdal, Zofia Lisowska-Petersen
Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort
Philipp Bosch, Alexandre Sepriano, Mary-Lucy Marques, Désirée van der Heijde, Robert Landewé, Miranda van Lunteren
A genome-wide association analysis reveals new pathogenic pathways in gout*
Tanya J. Major, Riku Takei, Hirotaka Matsuo, Megan P. Leask, Nicholas A. Sumpter, Ruth K. Topless
Ultrasound assessment of degenerative muscle sarcopenia: The University of Barcelona ultrasound scoring system for sarcopenia
Ingrid Möller Parera, Maribel Miguel, Joan Blasi, Riccardo Piccaso, Hilde Berner Hammer, Juan Ortiz-Sagrista
Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients
Anne Rydland, Fatima Heinicke, Siri Tennebø Flåm, Maria Dahl Mjaavatten, Benedicte Alexandra Lie
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review
Maud Wieczorek, Suzanne MM. Verstappen, Polina Putrik, James M. Gwinnutt, Andra Balanescu, Heike A. Bischoff-Ferrari
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type
Kristin Kaasen Jørgensen, Marte Lie Høivik, Adity Chopra, Jurate Saltyte Benth, Petr Ricanek, Bjørn Allan Moum
Mechanisms of vocational interventions for return to work from musculoskeletal conditions: a mediation analysis of the MI-NAV trial
Aidan G. Cashin, Britt Elin Øiestad, Fiona Aanesen, Kjersti Storheim, Alexander Tingulstad, Tarjei Langseth Rysstad
Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth V. Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas
Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort
Mylène P. Jansen, Frank W. Roemer, Anne Karien CA Marijnissen, Margreet Kloppenburg, Francisco J. Blanco, Ida Kristin Bos-Haugen
Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact
Catia Duarte, Tore Kristian Aaserud Kvien, Joseph Sexton, Eduardo Santos, Maarten De Wit, Laure Gossec
Associations Between Adherence to Self-Management Activities and Change in Function and Health Outcomes in the Rehabilitation of Patients with Rheumatic and Musculoskeletal Diseases
Helene Lindtvedt Hansen, Mari Klokkerud, Julie Hildeskår, Anne Sirnes Hagland, Egil Kjønli, Kristin Mjøsund
Quantitative CT of the knee in the IMI-APPROACH osteoarthritis cohort: Association of bone mineral density with radiographic disease severity, meniscal coverage and meniscal extrusion
Rafael Heiss, Jean-Denis Laredo, Wolfgang Wirth, Mylène P. Jansen, Anne CA Marijnissen, Floris Lafeber
Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study
Leanne Chen, Gregory D. Gamble, Anne Horne, Jill Drake, Anthony J. Doyle, Till Uhlig
Educational readiness among health professionals in rheumatology: low awareness of EULAR offerings and unfamiliarity with the course content as major barriers-results of an EULAR-funded European survey
Valentin Ritschl, Lisa Sperl, Margaret Renn Andrews, Mathilda Björk, Carina Boström, Jeannette Cappon
Combined Effects of Diet and Physical Activity on Inflammatory Joint Disease: A Systematic Review and Meta-Analysis
Petros C. Dinas, Rikke Helene Moe, Carina Boström, Rena I. Kosti, George D. Kitas, George S. Metsios
Longitudinal changes of serum cytokines in patients with chronic low back pain and Modic changes
Elisabeth Gjefsen, Kristina Gervin, Lars Christian Haugli Bråten, Guro Løvik Goll, Hans Christian Aass, Elina Iordanova Schistad
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis
Virginia Solitano, Antonio Facciorusso, Dermot PB McGovern, Tran Nguyen, Ruben J. Colman, Lily Zou
Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey
George S. Metsios, SAM Fenton, K. Tzika, Rikke Helene Moe, GE Fragoulis, TPM Vliet Vlieland
Automatic measuring of finger joint space width on hand radiograph using deep learning and conventional computer vision methods
Raj Ponnusamy, Ming Zhang, Zhiheng Chang, Yue Wang, Carmine Guida, Samantha Kuang
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
Marthe Kirkesæther Brun, Kristin Reine Hammersbøen, Marte Kathrine Viken, Grethe-Elisabeth Stenvik, Rolf Klaasen, Johanna Gehin
Associations between cardiovascular risk factors, disease activity and cardiorespiratory fitness in patients with inflammatory joint disease: a cross-sectional analysis
Kristine Røren Nordén, Anne Grete Semb, Hanne Dagfinrud, Jonny Hisdal, Sigrid Ødegård, Joseph Sexton
Evaluating Osteoarthritis Management Programs: outcome domain recommendations from the OARSI Joint Effort Initiative
KD Allen, K. Huffman, RJ Cleveland, der van der Esch, JH Abbott, A. Abbott
Patient-Reported Quality of Care for Osteoarthritis in General Practice in South Tyrol, Italy: Protocol for Translation, Validation and Assessment of the OsteoArthritis Quality Indicator Questionnaire (OA-QI)
Christian J. Wiedermann, Pasqualina Marino, Antje van der Zee-Neuen, Isabella Mastrobuono, Angelika Mahlknecht, Verena Barbieri
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Bente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, Dan C Nordström, Bjorn Gudbjornsson, Merete Lund Hetland
Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and Excellent Disease Control
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Daniel H. Solomon, Désirée Van Der Heijde
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Gheorghe A. Dan
Suitability of the animated activity questionnaire for use as computer adaptive test: establishing the AAQ-CAT
Gregor Liegl, Leo D. Roorda, Caroline B. Terwee, Martijn Steultjens, Ewa M. Roos, Francis Guillemin
How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway
Bénédicte Delcoigne, Sella Aarrestad Provan, Eirik Kristianslund, Johan Askling, Lotta Ljung
Is multimodal occupational therapy in addition to usual care cost-effective in people with thumb carpometacarpal osteoarthritis? A cost-utility analysis of a randomized controlled trial
Anne Therese Tveter, Linn Kleven, Nina Østerås, Randi Nossum, Ruth Else Meh Eide, Åse Klokkeide
Comorbidities in people with hand OA and their associations with pain severity and sensitization: Data from the longitudinal Nor-Hand study
Elisabeth Mulrooney, Tuhina Neogi, Hanne Dagfinrud, Hilde Berner Hammer, Pernille Steen Pettersen, Marthe Gløersen
A scoping review of how early-stage knee osteoarthritis has been defined
Jean W. Liew, Lauren K. King, Armaghan Mahmoudian, Qiuke Wang, Hayden F. Atkinson, David B. Flynn
Digitally delivered education and exercises for patients with hand osteoarthritis—An observational study
Matthias Michael Walter, Paulina Sirard, Håkan Nero, Helena Hörder, Leif E. Dahlberg, Anne Therese Tveter
Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study
Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm, WJ Taylor
Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyzes of a Randomized Trial (AIM Study)
Lars Christian Haugli Bråten, Elisabeth Gjefsen, Kristina Gervin, Are Hugo Pripp, Jan Sture Skouen, Elina Iordanova Schistad
Exploring Goals and Functional Changes in Reablement for People with Fractures and People with Dizziness and Balance Problems
Selma Licina, Ingvild Kjeken, Oddvar Førland, Eva Langeland, Hanne Kristin Tuntland
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
Mielnik Pawel, Joseph Sexton, Karen Minde Fagerli, Gunnstein Bakland, Yi Hu, Eirik Kristianslund
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods
Hilde Berner Hammer, Sigve Lars Pedersen, Maria Karolina Jonsson, Linda Mathsson-Alm, Isabel Gehring, Joseph Sexton
Patient engagement in the development and delivery of healthcare services: a systematic scoping review
Joachim Støren Sagen, Geir Smedslund, Ann Elisabeth Simonsen, Andreas Hanssønn Habberstad, Ingvild Kjeken, Hanne Dagfinrud
The WebRA study: Opportunities and challenges in digital patient education from the perspective of patients with rheumatoid arthritis: A qualitative study
Line Raunsbæk Knudsen, Kirsten Lomborg, Ellen-Margrethe Hauge, Heidi Andersen Zangi, Annette de Thurah
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
Asia-Sophia Fumika Michaela Wolf, Anthony Ravussin, Marton König, Mathias Herstad Øverås, Guri Solum, Ingrid Fadum Kjønstad
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomized controlled NORD-STAR trial
Mikkel Østergaard, Ronald F Van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf, Dan C Nordström
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Ioannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, Oliver Distler, Andrea Domján, Cornelia HM Van Den Ende
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level
Silvia Sirotti, Lene Terslev, Emilio Filippucci, Annamaria Iagnocco, Ingrid Moller, Esperanza Naredo
The efficacy of strength or aerobic exercise on quality of life and knee function in patients with knee osteoarthritis. A multi-arm randomized controlled trial with 1-year follow-up
Britt Elin Øiestad, Asbjørn Årøen, Jan H Røtterud, Nina Østerås, Even Jarstad, Margreth Grotle
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019)
Alen Brkic, Andreas P Diamantopoulos, Mari Hoff, Espen A. Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Antonela Botea, Nenad Damjanic, Gro Årthun Wivestad
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Lykke Midtbøll Ørnbjerg
Associations between pain sensitization and measures of physical function in people with hand osteoarthritis: Results from the Nor-Hand study
Marthe Gløersen, Pernille Steen Pettersen, Tuhina Neogi, Joseph Sexton, Tore Kristian Aaserud Kvien, Hilde Berner Hammer
Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study
Paweł Widera, Paco MJ Welsing, Samuel O. Danso, Sjaak Peelen, Margreet Kloppenburg, Marieke Loef
Negotiating Professional Tasks in a Hospital: A Qualitative Study of Rheumatologists and Occupational Therapists in the Management of Hand Osteoarthritis
Hege Johanne Magnussen, Ingvild Kjeken, Irma Pinxsterhuis, Trine Amalie Sjøvold, Marte Feiring
Hybrid and SARS-CoV-2 vaccine immunity in kidney transplant recipients
Hassen Kared, Amin Alirezaylavasani, Kathrine Persgård Lund, Adity Chopra, Lisa Tietze, Taissa de Matos Kasahara
Effect of tapered versus stable treatment with tumor necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonized Swedish, Danish and Norwegian cohorts
Helga Westerlind, Bente Glintborg, Hilde Berner Hammer, Saedis Saevarsdottir, Niels Steen Krogh, Merete Lund Hetland
Stricter treat-to-target in RA does not result in less radiographic progression: A longitudinal analysis in RA BIODAM
Sofia Ramiro, Robert Landewé, Désireé Van Der Heijde, Alexandre Sepriano, Oliver Fitzgerald, Mikkel Østergaard
Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway
Guro Løvik Goll, Tore Kristian Aaserud Kvien
Comparative effectiveness of pharmacological interventions for hand osteoarthritis: A systematic review and network meta-analysis of randomized trials
Anna Døssing, Sabrina Mai Nielsen, Féline PB Kroon, Ida Maria Balsby, Simon Tarp, Margreet Kloppenburg
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration
Louise Linde, Lykke M. Ørnbjerg, Simon H. Rasmussen, Thorvardur Jon Love, Anne Gitte Loft, Jakub Závada
Longer-term quality of care, effectiveness, and cost-effectiveness of implementing a model of care for osteoarthritis: A cluster-randomized controlled trial
Nina Østerås, Eline Aas, Tuva Moseng, Leti van Bodegom-Vos, Krysia Dziedzic, Bård Natvig
Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study
Emil Eirik Kvernberg Thomassen, Inger Jorid Berg, Eirik Klami Kristianslund, Anne Therese Tveter, Nina Østerås
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries
Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella Aarrestad Provan, Dan Nordström, Anna-Mari Hokkanen
Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study
Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Louise Linde, Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Karlsson Wallman, Daniela Di Giuseppe, Jakub Závada
Radiographic joint space width in individuals with hand osteoarthritis: Are their “healthy” joints really healthy?
Alexander Mathiessen, Immanuel Onuoha, Rebecca Luh, Jeffrey B. Driban, Mary B. Roberts, Charles B. Eaton
Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease—results from the nationwide Norwegian Cardio-rheuma registry
Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Amirhossein Kazemi, Sella Aarrestad Provan, Trine-Lise Larsen, Anne Grete Semb
Criterion Validity and Responsiveness of Estimated Cardiorespiratory Fitness Models in Patients with Inflammatory Joint Disease
Kristine Røren Nordén, Hanne Dagfinrud, Anne Grete Semb, Jonny Hisdal, George S. Metsios, Joseph Sexton
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Ingrid Jyssum, Johanna Gehin, Joseph Sexton, Eirik Kristianslund, Yi Hu, David Warren
Definition of rheumatoid arthritis flare based on SDAI and CDAI
Victoria Konzett, Andreas Kerschbaumer, Josef S. Smolen, Eirik Klami Kristianslund, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien
Effects of Analgesics on Self-Reported Physical Function and Walking Ability in People With Hip or Knee Osteoarthritis: A Systematic Review and Meta-Analysis
Silje Halvorsen Sveaas, Geir Smedslund, David A. Walsh, Hanne Solveig Dagfinrud
Reduced sleep quality is highly prevalent and associated with physical function and cardiorespiratory fitness in patients with axial spondyloarthritis: a cross-sectional study
Camilla Fongen, Hanne Solveig Dagfinrud, Annelie Bilberg, Silje Halvorsen Sveaas
Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study
Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm, Hilde Berner Hammer
Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network
Pasoon Hellamand, Marleen Van De Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael T Nurmohamed, Ronald F Van Vollenhoven
Work Ability in the Year after Rehabilitation—Results from the RehabNytte Cohort
Mari Nilsen Skinnes, Rikke Helene Moe, Thomas Johansen, Peter Solvoll Lyby, Kjersti Dahl, Idun Eid
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
Emma Dures, Bayram Farisoğulları, Eduardo José Ferreira Santos, Anna Molto, Caroline Feldthusen, Claire Harris
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial
Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik Kristianslund, Siri Lillegraven
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial
Kristina Lend, Frieda A. Koopman, Jon Lampa, Gerrit Jansen, Merete L. Hetland, Till Uhlig
Hand joints without radiographic osteoarthritis maintain their joint space width over 4 years despite what's happening elsewhere in the hand
Jeffrey B. Driban, Nhung Vo, Jeff Duryea, Lena F. Schaefer, Ida K. Haugen, Charles B. Eaton
Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial
Anna Døssing, Marius Henriksen, Karen Ellegaard, Sabrina Mai Nielsen, Lisa K Stamp, Felix C Müller
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock
Deep Learning for Predicting Progression of Patellofemoral Osteoarthritis Based on Lateral Knee Radiographs, Demographic Data and Symptomatic Assessments
Neslihan Bayramoglu, Martin Englund, Ida Kristin Bos-Haugen, Muneaki Ishijima, Simo Saarakkala
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Pasoon Hellamand, Marleen GH van de Sande, Lykke M. Ørnbjerg, Thomas Klausch, Kari K. Eklund, Heikki Relas
Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs
Alen Brkic, Andreas P Diamantopoulos, Espen A. Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke, Liz Paucar Loli
Associations between quality of health care and clinical outcomes in patients with rheumatic and musculoskeletal diseases: a rehabilitation cohort study
Anne-Lene Sand-Svartrud, Gunnhild Berdal, Maryam Azimi, Ingvild Bø, Turid Nygaard Dager, Siv Grødal Eppeland
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents
AM Kerola, Silvia Christin Hellerud Rollefstad, Amirhossein Kazemi, Grunde Wibetoe, Joseph Sexton, N. Mars
The AktiWeb study: feasibility of a web-based exercise program delivered by a patient organization to patients with hip and/or knee osteoarthritis
Kenth-Louis Hansen Joseph, Hanne Dagfinrud, Kåre Birger Hagen, Kristine Røren Nordén, Camilla Fongen, Ole-Martin Wold
Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach
Nicholas Fuggle, Nathalie Bere, Olivier Bruyère, Mario Manuel Rosa, María Concepción Prieto Yerro, Elaine Dennison
Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
Hilde Berner Hammer, Silvia Christin Hellerud Rollefstad, Anne Grete Semb, Gro Elisabeth Jensen, Lars Fridtjof Karoliussen, L Terslev
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
Annette De Thurah, Philipp Bosch, Andrea Marques, Yvette Meissner, Chetan B Mukhtyar, Johannes Knitza
Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data
Vibeke Norvang, Espen A. Haavardsholm, Sara K. Tedeschi, Houchen Lyu, Joseph Sexton, Maria Dahl Mjaavatten
Instrument selection for the ASAS core outcome set for axial spondyloarthritis
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Philip J Mease, Maxime Dougados, Uta Kiltz
The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort
M. Loef, de van de Stadt, S. Böhringer, A.-C. Bay-Jensen, A. Mobasheri, J. Larkin
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries
Silvia Christin Hellerud Rollefstad, Eirik Ikdahl, Grunde Wibetoe, Joseph Sexton, Cynthia S. Crowson, Piet van Riel
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit
Anne Grete Semb, Silvia Christin Hellerud Rollefstad, Joseph Sexton, Eirik Ikdahl, Cynthia S. Crowson, Piet van Riel
Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
Anne M. Kerola, Anne Grete Semb, Markus Juonala, Antti Palomäki, Päivi Rautava, Ville Kytö
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomized controlled trial
Kristina Lend, Ronald F van Vollenhoven, Jon Lampa, Merete Lund Hetland, Espen A. Haavardsholm, Dan Nordström
The genetic contribution to hand osteoarthritis
Karin Magnusson, Aleksandra Turkiewicz, Ida Kristin Bos-Haugen, Martin Trøan Englund
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Trung Tran, Joseph Sexton, Sella Aarrestad Provan
Organisation, influence, and impact of patient advisory boards in rehabilitation institutions—an exploratory cross-sectional study
Joachim Støren Sagen, Elin Børøsund, Ann Elisabeth Simonsen, Andreas Hanssønn Habberstad, Ingvild Kjeken, Hanne Dagfinrud
Risk factors for anti-drug antibody formation to infliximab: Secondary analyzes of a randomized controlled trial
Marthe Kirkesæther Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, Joseph Sexton, Johanna Elin Gehin, Øystein Sandanger
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study
AF Podewski, AM Glimm, I. Fischer, GAW Bruyn, P. Hanova, Hilde Berner Hammer
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Nghia H. Nguyen, Virginia Solitano, Sudheer K. Vuyyuru, John K. MacDonald, Silje Watterdal Syversen, Kristin Kaasen Jørgensen
Identification and Characterization of Trajectories of Sickness Absence Due to Musculoskeletal Pain: A 1-Year Population-based Study
Tarjei Langseth Rysstad, Margreth Grotle, Lene Aasdahl, Kate Dunn, Anne Therese Tveter
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments
Geir Smedslund, Martina Kotar, Till Uhlig
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia
Kristin Reine Hammersbøen, Jørgen Jahnsen, Jørn Brynskov, Pauliina Molander, Michael Eberhardson, Loà G. Davidsdottir
Implementation of recommendations in rheumatic and musculoskeletal diseases: Considerations for development and uptake
Estibaliz Loza, Loreto Carmona, Anthony Woolf, Bruno Fautrel, Delphine S Courvoisier, Suzanne Verstappen
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine
Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesæther Brun, Meghna Jani, Nils Bolstad, Silje Watterdal Syversen
Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
Nicola Veronese, Cyrus Cooper, Olivier Bruyère, Nasser M. Al-Daghri, Jaime Branco, Etienne Cavalier
Effect of a mHealth exercise intervention compared with supervised exercise therapy in osteoarthritis management: protocol of the DigiOA trial
Lars Martinsen, Nina Østerås, Tuva Moseng, Anne Therese Tveter
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study
Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung Tran, Siri Mjaaland
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Kvien, Espen A. Haavardsholm, F. Perez-Ruiz
Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology
Konstantinos C. Koskinas, Paul Dendale, Martin Halle, Stefano Caselli, Veronique Cornelissen, Maryam Kavousi
Advancing medical education - a brief report by the ESC Working Group on Cardiovascular Pharmacotherapy
Juan Carlos Kaski, Anne Grete Semb, Gianluigi Savarese
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout
Nicholas A Sumpter, Riku Takei, Murray Cadzow, Ruth Topless, Amanda Phipps-Green, Rinki Murphy
Effectiveness of adding motivational interviewing or a stratified vocational advice intervention to usual case management on return to work for people with musculoskeletal disorders: The MI-NAV randomized controlled trial
Fiona Aanesen, Margreth Grotle, Tarjei Langseth Rysstad, Anne Therese Tveter, Alexander Tingulstad, Ida Løchting
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Ingrid Egeland Christensen, Trung Tran
Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort
W. Wirth, S. Maschek, ACA Marijnissen, A. Lalande, FJ Blanco, F. Berenbaum
2021 EULAR recommendations regarding lifestyle behaviors and work participation to prevent progression of rheumatic and musculoskeletal diseases
James M Gwinnutt, Maud Wieczorek, Andra Balanescu, Heike A Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert BM Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Kristin H. Bjørlykke, Hilde Sofie Sager Ørbo, Anne Therese Tveter, Ingrid Jyssum, Joseph Sexton, Trung Tran
Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis
Frank Buttgereit, Tore Kristian Kvien
Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort
Eefje M. van Helvoort, Mylène P Jansen, Anne CA Marijnissen, Margreet Kloppenburg, Francisco J. Blanco, Ida Kristin Bos-Haugen
Prolonged morning stiffness is common in hand OA and does not preclude a diagnosis of hand osteoarthritis
de van de Stadt, Ida Kristin Bos-Haugen, D. Felson, M. Kloppenburg
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Charlotte LM Krieckaert, Astrid Van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
Imane Bardan, Karen Minde Fagerli, Joseph Sexton, Tore Kristian Aaserud Kvien, Gunnstein Bakland, Mielnik Pawel
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gomez-Reino, Kim Lauper, Denis Mongin, Florenzo Iannone
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Konstantin A. Krychtiuk, Ingo Ahrens, Heinz Drexel, Sigrun Halvorsen, Christian Hassager, Kurt Huber